Technology Platform Nutraceutical Development BM-A1 Clinical Trial Genetic Information Assessment Therapeutic Development Publications

Personalizing Health and Risk Assessment There are no two identical individuals. Genomic differences and environmental factors define our individualities. Among other things, our health, well-being and response to physical and chemicals factors of the environment are defined by the ways our cells work – not just the type, or allele, of individual genes we are carrying, but by levels of expression of the totality of genes in a given tissue or organ. On the systemic level, our tissues and organs communicate via proteins they secrete into the bloodstream, regulating functions as complex as the differentiation of the red blood cells (erythropoietin) and the level of glucose in blood (insulin). At BioMarker, we are investigating levels of transcription of select genes expressed in the blood, as well as levels of select proteins secreted in blood. This provides us the benefit of a large data set from which to make comparison to our database-derived biomarkers; while simultaneously providing a fast and minimally invasive system for the collection of data from individuals, which will allow us to provide flexible, real-time assessment and monitoring services.